Department of Medical Education, Akron Children's Hospital, Akron, Ohio.
Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Netw Open. 2023 Oct 2;6(10):e2339884. doi: 10.1001/jamanetworkopen.2023.39884.
The COVID-19 pandemic has been associated with a transient decrease in bronchiolitis hospitalizations compared with prepandemic patterns, but current effects remain unknown.
To analyze changes in patterns of bronchiolitis admissions at US children's hospitals during the 2020-2023 bronchiolitis seasons compared with the 2010-2019 seasons.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from 41 US children's hospitals in the Pediatric Health Information System database. Bronchiolitis has winter-predominant seasonality, so hospitalizations were grouped according to bronchiolitis season (from July through June). This study included all patients aged younger than 2 years admitted with a diagnosis of bronchiolitis between July 1, 2010, and June 30, 2023. Bronchiolitis seasons from July through June between 2010-2011 and 2019-2020 were classified as the prepandemic era, and seasons between 2020-2021 and 2022-2023 were classified as the pandemic era. Data analysis was performed from July 1, 2010, through June 30, 2023.
Admission date.
The primary outcome was number of hospitalizations for bronchiolitis by season and month. Monthly admission counts from the prepandemic era were transformed into time series and used to train seasonal ensemble forecasting models. Forecasts were compared to monthly admissions during the pandemic era.
In this study, there were 400 801 bronchiolitis admissions among 349 609 patients between July 1, 2010, and June 30, 2023. The median patient age was 6 (IQR, 2-12) months; 58.7% were boys and 43.7% were White. Hospitalizations increased gradually during the prepandemic era (median, 29 309 [IQR, 26 196-34 157]), decreased 69.2% (n = 9030) in the 2020-2021 season, and increased 75.3% (n = 51 397) in the 2022-2023 season. Patients in the pandemic era were older than those in the prepandemic era (median, 7 [IQR, 3-14] vs 6 [2-12] months; P < .001). Intensive care unit (ICU) admissions increased from 32.2% (96 245 of 298 535) in the prepandemic era to 36.7% (37 516 of 102 266) in the pandemic era (P < .001). The seasonality of bronchiolitis admissions changed during the pandemic era. Admissions peaked in August 2021 (actual 5036 vs 943 [95% CI, 0-2491] forecasted) and November 2022 (actual 10 120 vs 5268 [95% CI, 3425-7419] forecasted). These findings were unchanged in sensitivity analyses excluding children with complex chronic conditions and excluding repeat admissions. In a sensitivity analysis including all viral lower respiratory tract infections in children aged younger than 5 years, there were 66 767 admissions in 2022-2023 vs 35 623 (31 301-41 002) in the prepandemic era, with the largest increase in children aged 24 to 59 months.
The findings of this cross-sectional study suggest that bronchiolitis hospitalizations decreased transiently and then increased markedly during the COVID-19 pandemic era. Patients admitted during the pandemic era were older and were more likely to be admitted to an ICU. These findings suggest that bronchiolitis seasonality has not yet returned to prepandemic patterns, and US hospitals should prepare for the possibility of atypical timing again in 2023.
与大流行前模式相比,COVID-19 大流行与毛细支气管炎住院人数短暂下降有关,但目前的影响仍不清楚。
分析 2020-2023 年美国儿童医院毛细支气管炎发病季节与 2010-2019 年季节相比的变化模式。
设计、设置和参与者:本回顾性横断面研究使用了来自 41 家美国儿童医院的儿科健康信息系统数据库中的数据。毛细支气管炎具有冬季高发的季节性,因此根据毛细支气管炎季节(7 月至 6 月)对住院情况进行分组。本研究包括所有年龄在 2 岁以下、诊断为毛细支气管炎的患者,他们在 2010 年 7 月 1 日至 2023 年 6 月 30 日期间住院。2010-2011 年和 2019-2020 年的毛细支气管炎季节被归类为大流行前时期,2020-2021 年和 2022-2023 年的季节被归类为大流行时期。数据分析于 2010 年 7 月 1 日至 2023 年 6 月 30 日进行。
入院日期。
主要结果是每个季节和每月的毛细支气管炎住院人数。大流行前时期的每月入院人数被转化为时间序列,并用于训练季节性集合预测模型。预测结果与大流行期间的每月入院情况进行了比较。
在这项研究中,在 2010 年 7 月 1 日至 2023 年 6 月 30 日期间,349609 名患者中有 400801 名毛细支气管炎患者住院。患者的中位年龄为 6 个月(IQR,2-12 个月);58.7%为男性,43.7%为白人。在大流行前时期,住院人数逐渐增加(中位数为 29309 例[IQR,26196-34157]),2020-2021 年下降 69.2%(n=9030),2022-2023 年增加 75.3%(n=51397)。大流行时期的患者比大流行前时期的患者年龄更大(中位数为 7 个月[IQR,3-14] vs 6 个月[2-12];P<.001)。重症监护病房(ICU)入院率从大流行前时期的 32.2%(298535 例中的 96245 例)增加到大流行时期的 36.7%(102266 例中的 37516 例)(P<.001)。毛细支气管炎入院的季节性在大流行期间发生了变化。2021 年 8 月的入院人数达到高峰(实际为 5036 例,95%CI,0-2491 例预测),2022 年 11 月达到 10120 例(实际为 10120 例,95%CI,7419 例)。在排除患有复杂慢性疾病的儿童和重复入院的敏感性分析中,这些发现保持不变。在一项包括所有年龄在 5 岁以下的病毒性下呼吸道感染的儿童的敏感性分析中,2022-2023 年有 66767 例入院,而大流行前时期有 35623 例(31301-41002 例),24 至 59 个月的儿童入院人数增幅最大。
这项横断面研究的结果表明,毛细支气管炎住院人数在 COVID-19 大流行期间短暂下降,然后显著增加。大流行期间入院的患者年龄更大,更有可能被收治到 ICU。这些发现表明,毛细支气管炎的季节性尚未恢复到大流行前模式,美国医院应再次为 2023 年可能出现的非典型时间做好准备。